Company Profile
Fresenius Kabi Oncology Limited is a public listed company primarily operating in the field of Research & Development and manufacturing of world-class oncology drugs. The company strives to provide most advanced third generation chemotherapeutic drugs right from development to manufacturing & marketing across the globe. It is fast emerging as a leading player in oncology generics on the strength of its comprehensive product portfolio of injectables, oral cytotoxics, cytostatics, intermediates and active pharmaceutical ingredients (APIs).
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
Ambroxol hydrochloride |
Cyclohexanol,4-[[(2-amino-3,5-dibromophenyl)methyl]amino]-,hydrochloride (1:1),trans-;Cyclohexanol,4-[(2-amino-3,5-dibromobenzyl)amino]-,hydrochloride,trans-;Cyclohexanol,4-[[(2-amino-3,5-dibromophenyl)methyl]amino]-,monohydrochloride,trans-;trans-4-[(2-Amino-3,5-dibromobenzyl)amino]cyclohexanol hydrochloride;N-(trans-4-Hydroxycyclohexyl)-2-amino-3,5-dibromobenzylamine hydrochloride;Ambroxol hydrochloride;Mucolear;Mucosolvan;Surbronc;Mucolin;Ambril;Lindoxyl;Muco-Burg;Mucovent;Stas-Hustenloser;Mucofar;Abramen;Solvolan;Mucasan;Surfactal;Fluibron;Motosol;Pect;Frenopect;Duramucal;Mucoclear;Fluixol;Bronchopront;Coughnol;Ambron;Ambrodil;Mucolite;Mucosal;Ambrolite;108728-04-7;15942-05-9 |
23828-92-4 | Inquiry |
CONTACT INFORMATION
Sign In for Details